118
B. Füger et al.
LETTER
(10) (a) Lacôte, E.; Amatore, M.; Fensterbank, L.; Malacria, M.
Synlett 2002, 116. (b) Leca, D.; Song, K.; Amatore, M.;
Fensterbank, L.; Lacote, E.; Malacria, M. Chem. Eur. J.
2004, 10, 906.
(11) For recently developed alternative imination protocols, see:
(a) Okamura, H.; Bolm, C. Org. Lett. 2004, 6, 1305.
(b) Cho, G. Y.; Bolm, C. Org. Lett. 2005, 7, 4983. (c) Cho,
G. Y.; Bolm, C. Tetrahedron Lett. 2005, 46, 8007. (d) Refs
6 and 7.
References and Notes
(1) For selected recent contributions, see: (a) Reggelin, M.;
Kuehl, J.; Kaiser, J. P.; Buehle, P. Synthesis 2006, 2224.
(b) Rajender, A.; Gais, H.-J. Org. Lett. 2007, 9, 579.
(c) Adrien, A.; Gais, H.-J.; Koehler, F.; Runsink, J.; Raabe,
G. Org. Lett. 2007, 9, 2155.
(2) (a) Bolm, C.; Müller, D.; Dalhoff, C.; Hackenberger, C. P.
R.; Weinhold, E. Bioorg. Med. Chem. Lett. 2003, 13, 3207.
(b) Cho, G. Y.; Okamura, H.; Bolm, C. J. Org. Chem. 2005,
70, 2346 and references therein.
(12) In the reactions reported here, racemic sulfoximines were
used.
(3) Reviews: (a) Harmata, M. Chem. Abstr. 2003, 16, 660.
(b) Okamura, H.; Bolm, C. Chem. Lett. 2004, 33, 482.
(4) Reviews: (a) Johnson, C. R. Acc. Chem. Res. 1973, 6, 341.
(b) Pyne, S. G. Sulfur Rep. 1992, 12, 57. (c) Reggelin, M.;
Zur, C. Synthesis 2000, 1. (d) Bolm, C. In Asymmetric
Synthesis with Chemical and Biological Methods; Enders,
D.; Jäger, K.-E., Eds.; Wiley-VCH: Weinheim, 2007, 149.
(5) For a selection of recent patents emphasizing this point, see:
(a) Luecking, U.; Krüger, M.; Jautelat, R.; Siemeister, G.
WO 037800 A1, 2005; Schering AG. (b) Luecking, U.;
Siemeister, G.; Jautelat, R. WO 099974 A1, 2006; Schering
AG. (c) Luecking, U.; Nguyen, D.; von Bonin, A.; von
Ahsen, O.; Krueger, M.; Briem, H.; Kettschau, H.; Prien, O.;
Mengel, A.; Krolikiewicz, K.; Boemer, U.; Bothe, U.;
Hartung, I. WO 071455 A1, 2007; Schering AG.
(13) The interactions between the benzylic hydrogens and the
hydrogens of the alkyl or alkoxy chain in the 1H-NOESY
spectra also confirmed the molecular structures of triazole
derivatives 3b–e,g,h. Although present in the crude product
mixtures, the other regioisomers (triazoles 5) could never be
obtained in pure form (Figure 1).
Ts
N
S
R2
R1
O
R3
N
N
N
5
Figure 1
(d) Luecking, U. EP 1 710 246 A1, 2006; Schering AG.
(e) Luecking, U.; Bader, B.; Siemeister, G. EP 1 803 723 A1,
2007; Bayer Schering Pharma. (f) Shetty, S. J.; Patel, G. D.;
Lohray, B. B.; Lohray, V. B.; Chakrabarti, G.; Chatterjee,
A.; Jain, M. J.; Patel, P. R. WO 077574 A2, 2007; Cadila
Healthcare Limited. (g) Zhu, Y.; Rogers, R. B.; Huang, Y.
X. US 228027 A1, 2005; Dow Agroscience.
(h) Jeanguenat, A.; O’Sullivan, A. C. WO 032462 A1, 2006;
Syngenta. (i) Jeanguenat, A.; O’Sullivan, A. C. WO 061200
A1, 2006; Syngenta. (j) Plant, A.; Boehmer, J. E.; Peace, A.
L. WO 037945 A1, 2006; Syngenta. (k) Kajita, S.; Ohmura,
H.; Akashi, M.; Kojima, S.; Satoh, A.; Tomida, K. WO
052849, 2004; Nippon Soda Co., Ltd.
(14) General Procedure for the Cycloaddition Reaction
Under vigorous stirring a mixture of NaN3 (12 equiv) and the
corresponding bromide (15 equiv) was heated to reflux in
H2O (0.7 M) for 1 h. Then, a solution of sulfoximine 4 (1
equiv) in CH2Cl2 (0.08 M) was added dropwise. After 3 h at
100 °C under reflux and stirring, the product was extracted
with CH2Cl2 and purified by flash column chromatography.
As representative example, the analytical data for 1-benzyl-
5-butyl-4-(N-tosyl)-(4-methylphenylsulfonimidoyl)-1H-
1,2,3-triazole (3a) obtained from the reaction of sulfoximine
4a with benzyl azide are given. Colorless oil (68%);
chromatography: EtOAc–pentane (1:3). 1H NMR (400
MHz, CDCl3): d = 0.79 (t, J = 7.0 Hz, 3 H), 1.21–1.29 (m, 4
H), 2.37 (s, 3 H), 2.41 (s, 3 H), 2.76–2.85 (m, 1 H), 2.93–3.02
(m, 1 H), 5.44 (d, J = 15.5 Hz, 1 H), 5.49 (d, J = 15.5 Hz, 1
H), 7.14–7.18 (m, 2 H), 7.20 (d, J = 8.0 Hz, 2 H), 7.31–7.35
(m, 5 H), 7.80 (d, J = 8.3 Hz, 2 H), 7.98 (d, J = 8.5 Hz, 2 H).
13C NMR (100 MHz, CDCl3): d = 13.6 (CH3), 21.5 (CH3),
21.7 (CH3), 22.7 (CH2), 23.0 (CH2), 30.5 (CH2), 52.5 (CH2),
126.5 (CH), 127.2 (CH), 128.2 (CH), 128.7 (CH), 129.0
(2 × CH), 129.9 (CH), 133.5 (C), 135.2 (C), 140.4 (C), 141.4
(C), 141.9 (C), 142.6 (C), 145.4 (C). IR (CHCl3): n = 2959
(m), 1454 (m), 1318 (m), 1243 (m), 1096 (s), 1018 (m), 757
(s), 540 (m). MS (CI): m/z (relative intensity) = 523 (6) [M
+ H]+. Anal. Calcd for C27H30N4S2O3: C, 62.04; H, 5.79; N,
10.72. Found: C, 62.06; H, 5.81; N, 11.14.
(6) Garcia Mancheño, O.; Bolm, C. Org. Lett. 2006, 8, 2349.
(7) Garcia Mancheño, O.; Bistri, O.; Bolm, C. Org. Lett. 2007,
9, 3809.
(8) For regioselective syntheses and applications of triazoles,
see: (a) Butler, R. N. In Comprehensive Heterocyclic
Chemistry, Vol. 4; Katritzky, A. R.; Rees, C. W.; Scriven, E.
F. V., Eds.; Pergamon: Oxford UK, 1996, 121. (b) Yoo, E.
J.; Ahlquist, M.; Kim, S. H.; Bae, I.; Fokin, V. V.; Sharpless,
K. B.; Chang, S. Angew. Chem. Int. Ed. 2007, 46, 1730.
Reviews: (c) Bock, V. D.; Hiemstra, H.; van Maarseveen, J.
H. Eur. J. Org. Chem. 2006, 51. (d) Lutz, J. F. Angew.
Chem. Int. Ed. 2007, 46, 1018.
(9) Sklute, G.; Bolm, C.; Marek, I. Org. Lett. 2007, 9, 1259.
Synlett 2008, No. 1, 116–118 © Thieme Stuttgart · New York